What are the Considerations in Balancing Benefits and Risks in Iron Treatment?-Reference-Cited by-同舟云学术

What are the Considerations in Balancing Benefits and Risks in Iron Treatment?

Published:2016-10-20 Issue:1 Volume:30 Page:25-27
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Semin Dial

Author:

Alan Brookhart M.¹²,Li Xiaojuan¹³,Kshirsagar Abhijit V.³

Affiliation:

1. Department of Epidemiology; UNC Gillings School of Global Public Health; UNC Chapel Hill; Chapel Hill North Carolina

2. Cecil G. Sheps Center for Health Services Research; University of North Carolina; Chapel Hill North Carolina

3. UNC School of Medicine; University of North Carolina Kidney Center; Chapel Hill North Carolina

Funder

National Institutes of Health

Patient Centered Outcomes Research Institute

Amgen

AstraZeneca

T32 National Institutes of Health Training Grant in Renal Epidemiology

Publisher

Wiley

Subject

Nephrology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12550/fullpdf

Reference24 articles.

1. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%;Collins;J Am Soc Nephrol,2001

2. Changing patterns of anemia management in US hemodialysis patients;Freburger;Am J Med,2012

3. Trends in anemia management in US hemodialysis patients 2004-2010;Miskulin;BMC Nephrol,2013

4. Understanding the recent increase in ferritin levels in United States dialysis patients: potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing;Karaboyas;Clin J Am Soc Nephrol,2015

5. Parenteral versus oral iron therapy for adults and children with chronic kidney disease;Albaramki;Cochrane Database Syst Rev,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of intravenous iron in hemodialysis patients;Hemodialysis International;2017-04